Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.
Dublin, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The "Blood Group Typing Market by Product (Consumables, Instruments, Services), Test Type (ABO, Antigen, Antibody, HLA ...
Genomic testing based on chromosome microarray (CMA) and Next Generation Sequencing (NGS) revolutionized clinical genetics. That said, microarray, targeted panel, exome and generic whole genome ...
Different applications have different requirements, so researchers need to carefully weigh their options when deciding whether to switch to a new platform. [© WavebreakmediaMicro – Fotolia.com] With ...
Dublin, June 02, 2023 (GLOBE NEWSWIRE) -- The "Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR ...
Perhaps no technology better embodies the spirit of the post-genomics age than the microarray. If genome sequencing projects listed the parts that make up an organism – be it a mouse, a fly, or a ...
In 2005, two landmark papers describing novel cycle-array sequencing methods ushered in a new era in genetics. Known at the time as next-generation sequencing (NGS), these methods are now more ...
Researchers at Baylor College of Medicine and Roche NimbleGen Inc. have published details of an efficient and cost-effective method for capturing targeted regions of the genome via NimbleChip™ ...
This market is poised to grow at a CAGR of 15.1% from 2013-2019. Key players of this market include Abbott Laboratories, Roche Diagnostics, Novartis Diagnostics, Hologic Gen-Probe, Qiagen, and Cepheid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback